WOLF; Marie-Christine
Patent Applications and Registrations
Patent applications and USPTO patent grants for WOLF; Marie-Christine.The latest application filed is for "therapeutic regimen".
- WOLF; Marie-Christine - St. Louis FR
- Wolf; Marie-Christine - Basel CH
| Patent | Date |
|---|---|
| Therapeutic Regimen App 20220088022 - JAIN; Jay Prakash ; et al. | 2022-03-24 |
| Preparation of and formulation comprising a MEK inhibitor Grant 10,729,678 - Krell , et al. | 2020-08-04 |
| Preparation Of And Formulation Comprising A Mek Inhibitor App 20200171002 - Krell; Christoph Max ; et al. | 2020-06-04 |
| Therapeutic Regimen App 20200171037 - JAIN; Jay Prakash ; et al. | 2020-06-04 |
| Preparation of and formulation comprising a MEK inhibitor Grant 10,398,683 - Krell , et al. Sep | 2019-09-03 |
| Therapeutic Regimen App 20180303837 - JAIN; Jay Prakash ; et al. | 2018-10-25 |
| Preparation Of And Formulation Comprising A Mek Inhibitor App 20180296533 - Krell; Christoph Max ; et al. | 2018-10-18 |
| Preparation of and formulation comprising a MEK inhibitor Grant 9,980,944 - Krell , et al. May 29, 2 | 2018-05-29 |
| Preparation Of And Formulation Comprising A Mek Inhibitor App 20170231963 - Krell; Christoph Max ; et al. | 2017-08-17 |
| Preparation of and formulation comprising a MEK inhibitor Grant 9,598,376 - Krell , et al. March 21, 2 | 2017-03-21 |
| Preparation of and formulation comprising a MEK inhibitor Grant 9,562,016 - Krell , et al. February 7, 2 | 2017-02-07 |
| Preparation of and formulation comprising a MEK inhibitor Grant 9,382,212 - Krell , et al. July 5, 2 | 2016-07-05 |
| Preparation Of And Formulation Comprising A Mek Inhibitor App 20160168103 - Krell; Christoph Max ; et al. | 2016-06-16 |
| Preparation Of And Formulation Comprising A Mek Inhibitor App 20160168104 - Krell; Christoph Max ; et al. | 2016-06-16 |
| Preparation Of And Formulation Comprising A Mek Inhibitor App 20160168102 - Krell; Christoph Max ; et al. | 2016-06-16 |
| Preparation of and formulation comprising a MEK inhibitor Grant 9,238,627 - Krell , et al. January 19, 2 | 2016-01-19 |
| Preparation Of And Formulation Comprising A Mek Inhibitor App 20140128442 - Krell; Christoph Max ; et al. | 2014-05-08 |
| Galenical Formulations Of Organic Compounds App 20100209480 - Altenburger; Ralf ; et al. | 2010-08-19 |
| Pharmaceutical Composition Comprising an Indolylmaleimide Derivative App 20080187582 - Guitard; Patrice ; et al. | 2008-08-07 |
| Oral matrix formulations comprising licarbazepine App 20070196488 - Kalb; Oskar ; et al. | 2007-08-23 |
| Disintegrating tablets comprising licarb azepine App 20070190143 - Kalb; Oskar ; et al. | 2007-08-16 |
| Modified release formulations of oxcarbazepine and derivatives thereof App 20060057203 - Wolf; Marie-Christine ; et al. | 2006-03-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 